Identification of organoselenium compounds that possess chemopreventive properties in human prostate cancer LNCaP cells

Bioorganic and Medicinal Chemistry

Volumn 18, Issue 19, 2010, Pages 7001-7008

  Terazawa, Riyako ^a   Garud, Dinesh R ^b,e   Hamada, Nanako ^a   Fujita, Yasunori ^a   Itoh, Tomohiro ^a   Nozawa, Yoshinori ^a,c   Nakane, Keita ^d   Deguchi, Takashi ^d   Koketsu, Mamoru ^b   Ito, Masafumi ^a  

^a GIFU INTERNATIONAL INSTITUTE OF BIOTECHNOLOGY   (Japan)

^b GIFU UNIVERSITY   (Japan)

^c Tokai Women's Junior College   (Japan)

^d GIFU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e Sir Parashurambhau College   (India)

Author keywords

Antioxidant response element; Cell growth inhibition; Chemoprevention; Heme oxygenase 1; Nrf2; Organoselenium compound; Oxidative stress; Prostate cancer

Indexed keywords

3 SELENA 1 DETHIACEPHEM; ANTINEOPLASTIC AGENT; ANTIOXIDANT; HEME OXYGENASE 1; ORGANOSELENIUM DERIVATIVE; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIOXIDANT RESPONSIVE ELEMENT; ARTICLE; CANCER CELL; CANCER INHIBITION; CELL CYCLE ARREST; CELL NUCLEUS; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DRUG SYNTHESIS; GENE TRANSLOCATION; HUMAN; HUMAN CELL; OXIDATIVE STRESS; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN INDUCTION;

ANTINEOPLASTIC AGENTS; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; DRUG SCREENING ASSAYS, ANTITUMOR; HEME OXYGENASE-1; HUMANS; MALE; MOLECULAR CONFORMATION; NF-E2-RELATED FACTOR 2; ORGANOSELENIUM COMPOUNDS; OXIDATIVE STRESS; PROSTATIC NEOPLASMS; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; STEREOISOMERISM; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 77956652144     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2010.08.019     Document Type: Article

References (27)

1. H.C. Pitot Cancer 49 1982 1206
2. Y.J. Surh Nat. Rev. Cancer 3 2003 768
3. D.N. Syed, N. Khan, F. Afaq, and H. Mukhtar Cancer Epidemiol. Biomarkers Prev. 16 2007 2193
4. W.C. Willett, B.F. Polk, J.S. Morris, M.J. Stampfer, S. Pressel, B. Rosner, J.O. Taylor, K. Schneider, and C.G. Hames Lancet 2 1983 130
5. O.P. Heinonen, D. Albanes, J. Virtamo, P.R. Taylor, J.K. Huttunen, A.M. Hartman, J. Haapakoski, N. Malila, M. Rautalahti, S. Ripatti, H. Maenpaa, L. Teerenhovi, L. Koss, M. Virolainen, and B.K. Edwards J. Natl. Cancer Inst. 90 1998 440
6. T.M. Vogt, R.G. Ziegler, B.I. Graubard, C.A. Swanson, R.S. Greenberg, J.B. Schoenberg, G.M. Swanson, R.B. Hayes, and S.T. Mayne Int. J. Cancer 103 2003 664
7. E.A. Klein, I.M. Thompson, S.M. Lippman, P.J. Goodman, D. Albanes, P.R. Taylor, and C. Coltman Urol. Oncol. 21 2003 59
8. S.M. Lippman, E.A. Klein, P.J. Goodman, M.S. Lucia, I.M. Thompson, L.G. Ford, H.L. Parnes, L.M. Minasian, J.M. Gaziano, J.A. Hartline, J.K. Parsons, J.D. Bearden 3rd, E.D. Crawford, G.E. Goodman, J. Claudio, E. Winquist, E.D. Cook, D.D. Karp, P. Walther, M.M. Lieber, A.R. Kristal, A.K. Darke, K.B. Arnold, P.A. Ganz, R.M. Santella, D. Albanes, P.R. Taylor, J.L. Probstfield, T.J. Jagpal, J.J. Crowley, F.L. Meyskens Jr., L.H. Baker, and C.A. Coltman Jr. JAMA 301 2009 39
9. N. Khan, F. Afaq, and H. Mukhtar Antioxid. Redox Signal. 10 2008 475
10. T. Nguyen, C.S. Yang, and C.B. Pickett Free Radical Biol. Med. 37 2004 433
11. E. Balogun, M. Hoque, P. Gong, E. Killeen, C.J. Green, R. Foresti, J. Alam, and R. Motterlini Biochem. J. 371 2003 887
12. A.T. Dinkova-Kostova, W.D. Holtzclaw, R.N. Cole, K. Itoh, N. Wakabayashi, Y. Katoh, M. Yamamoto, and P. Talalay Proc. Natl. Acad. Sci. U.S.A. 99 2002 11908
13. J.D. Hayes, and M. McMahon Cancer Lett. 174 2001 103
14. S. Jana, and S. Mandlekar Curr. Drug Metab. 10 2009 595
15. R. Naithani Mini Rev. Med. Chem. 8 2008 657
16. Y.Y.C. Nakamura, A. Murakami, H. Ohigashi, T. Osawa, and K. Uchida FEBS Lett. 572 2004 245
17. A. Muller, E. Cadenas, P. Graf, and H. Sies Biochem. Pharmacol. 33 1984 3235
18. T. Satoh, K. Ishige, and Y. Sagara Neurosci. Lett. 371 2004 1
19. T. Sakurai, M. Kanayama, T. Shibata, K. Itoh, A. Kobayashi, M. Yamamoto, and K. Uchida Chem. Res. Toxicol. 19 2006 1196
20. S.J. Kim, C. Park, A.L. Han, M.J. Youn, J.H. Lee, Y. Kim, E.S. Kim, H.J. Kim, J.K. Kim, H.K. Lee, S.Y. Chung, H. So, and R. Park Hear. Res. 251 2009 70
21. H.C. Choi, K.Y. Lee, D.H. Lee, and Y.J. Kang Korean J. Physiol. Pharmacol. 13 2009 309
22. C.I. Schwer, M. Mutschler, P. Stoll, U. Goebel, M. Humar, A. Hoetzel, and R. Schmidt Mol. Pharmacol. 77 2010 660
23. Y.M. Lee, G.S. Jeong, H.D. Lim, R.B. An, Y.C. Kim, and E.C. Kim Toxicol. In Vitro 24 2010 776
24. D.R. Garud, and M. Koketsu Org. Lett. 10 2008 3319
25. Y. Morimitsu, Y. Nakagawa, K. Hayashi, H. Fujii, T. Kumagai, Y. Nakamura, T. Osawa, F. Horio, K. Itoh, K. Iida, M. Yamamoto, and K. Uchida J. Biol. Chem. 277 2002 3456
26. K. Umemura, T. Itoh, N. Hamada, Y. Fujita, Y. Akao, Y. Nozawa, N. Matsuura, M. Iinuma, and M. Ito Biochem. Biophys. Res. Commun. 368 2008 948
27. J.M. Lee, M.J. Calkins, K. Chan, Y.W. Kan, and J.A. Johnson J. Biol. Chem. 278 2003 12029